US Patent Issued to Ensysce Biosciences on May 26 for "Modified release compositions of nafamostat and methods of using same" (California Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,253, issued on May 26, was assigned to Ensysce Biosciences Inc. (La Jolla, Calif.).

"Modified release compositions of nafamostat and methods of using same" was invented by Lynn Kirkpatrick (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present disclosure include a composition of nafamostat or a pharmaceutically acceptable salt thereof that provides for controlled release of nafamostat or pharmaceutically acceptable salt thereof to a subject for an extended period of time. Compositions according to certain embodiments include a plurality of controlled release beads where each bead includes a core, an active agent layer...